Regensburg Center for Interventional Immunology adopts LUMICKS' z-Movi® Cell Avidity Analyzer
/PRNewswire/ -- In its effort to develop effective cellular immunotherapies for cancer treatment, the Regensburg Center for Interventional Immunology (RCI) in...
Source: prnewswire.com